132 related articles for article (PubMed ID: 31056822)
1. A qualitative study on decision-making about BRCA1/2 testing in Italian women.
Battistuzzi L; Franiuk M; Kasparian N; Rania N; Migliorini L; Varesco L
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13083. PubMed ID: 31056822
[TBL] [Abstract][Full Text] [Related]
2. Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.
Augestad MT; Høberg-Vetti H; Bjorvatn C; Sekse RJ
J Genet Couns; 2017 Feb; 26(1):182-189. PubMed ID: 27465808
[TBL] [Abstract][Full Text] [Related]
3. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
4. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
Nippert I; Schlegelberger B;
Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
[TBL] [Abstract][Full Text] [Related]
5. Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.
Manchanda R; Burnell M; Gaba F; Sanderson S; Loggenberg K; Gessler S; Wardle J; Side L; Desai R; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
BJOG; 2019 May; 126(6):784-794. PubMed ID: 30767407
[TBL] [Abstract][Full Text] [Related]
6. Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.
Grimmett C; Brooks C; Recio-Saucedo A; Armstrong A; Cutress RI; Gareth Evans D; Copson E; Turner L; Meiser B; Wakefield CE; Eccles D; Foster C
Support Care Cancer; 2019 Jan; 27(1):297-309. PubMed ID: 29955974
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer.
Grimmett C; Pickett K; Shepherd J; Welch K; Recio-Saucedo A; Streit E; Seers H; Armstrong A; Cutress RI; Evans DG; Copson E; Meiser B; Eccles D; Foster C
Patient Educ Couns; 2018 May; 101(5):779-788. PubMed ID: 29225062
[TBL] [Abstract][Full Text] [Related]
8. An Applied Framework in Support of Shared Decision Making about
Silverman TB; Kuperman GJ; Vanegas A; Sin M; Dimond J; Crew KD; Kukafka R
AMIA Annu Symp Proc; 2018; 2018():961-969. PubMed ID: 30815139
[TBL] [Abstract][Full Text] [Related]
9. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
Flores KG; Steffen LE; McLouth CJ; Vicuña BE; Gammon A; Kohlmann W; Vigil L; Dayao ZR; Royce ME; Kinney AY
J Genet Couns; 2017 Jun; 26(3):480-490. PubMed ID: 27496122
[TBL] [Abstract][Full Text] [Related]
11. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management.
Marchina E; Fontana MG; Speziani M; Salvi A; Ricca G; Di Lorenzo D; Gervasi M; Caimi L; Barlati S
Oncol Rep; 2010 Dec; 24(6):1661-7. PubMed ID: 21042765
[TBL] [Abstract][Full Text] [Related]
13. Beyond BRCA1 and BRCA2.
King-Spohn K; Pilarski R
Curr Probl Cancer; 2014; 38(6):235-48. PubMed ID: 25497410
[TBL] [Abstract][Full Text] [Related]
14. Early adoption of BRCA1/2 testing: who and why.
Armstrong K; Weiner J; Weber B; Asch DA
Genet Med; 2003; 5(2):92-8. PubMed ID: 12644778
[TBL] [Abstract][Full Text] [Related]
15. A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women.
Cortesi L; Razzaboni E; Toss A; De Matteis E; Marchi I; Medici V; Tazzioli G; Andreotti A; De Santis G; Pignatti M; Federico M
Ann Oncol; 2014 Jan; 25(1):57-63. PubMed ID: 24276029
[TBL] [Abstract][Full Text] [Related]
16. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
17. Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees.
van Driel CMG; Oosterwijk JC; Meijers-Heijboer EJ; van Asperen CJ; Zeijlmans van Emmichoven IA; de Vries J; Mourits MJE; Henneman L; Timmermans DRM; de Bock GH
Breast; 2016 Dec; 30():66-72. PubMed ID: 27639031
[TBL] [Abstract][Full Text] [Related]
18. Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study.
Godino L; Jackson L; Turchetti D; Hennessy C; Skirton H
Eur J Hum Genet; 2018 Jan; 26(1):44-53. PubMed ID: 29162934
[TBL] [Abstract][Full Text] [Related]
19. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
